Selected Publications By the Members of the MSS (2002)

  1. Balch CM, Soong S-j, Thompson JF, Buzaid A. Prognostic Factors and Staging of Melanoma. Progress in Oncology 2002, Jones and Bartlett Publishers, Boston, Massachusetts, 2002.
  2. Desmond R, Weiss HL, Arani RB, Soong S-j , Wood MJ, Fiddian PA, Gnann JW, Whitley RJ. Clinical Applications for Change-point Analysis of Herpes Zoster Pain. Journal of Pain and Symptom Management23:509-515, 2002.
  3. Santiago ML, Rodenburg CM, Kamenya S, Bibollet-Ruche F, Gao F, Bailes E, Meleth S, Soong S-j, Kilby JM, Moldoveanu Z, Fahey B, Muller MN, Ayouba A, Nerrienet E, McClure HM, Heeney JL, Pusey AE, Collins DA, Boesch C, Wrangham RW, Goodall J, Sharp PM, Shaw GM, Hahn BH. Simian Immunodeficiency Virus Infection in Wild-Living Pan Troglodytes Schweinfurthii Chimpanzees. Science465, 2002.
  4. Straughn Jr. JM, Hugh WK, Kelly FJ, Leath III CA, Kleinberg MJ, Hyde Jr. J, Nummum TM, ZhangY,Soong S-j, Austin Jr. JM, Partridge EE, Kilgore LC, Alvarez RD: Conservative Management of Stage I Endometrial Carcinoma After Surgical Staging. Gynecologic Oncology 84:194-200, 2002.
  5. Accortt NA , Waterbor JW, Beall C, Howard G. Chronic Disease Mortality in a Cohort of Smokeless Tobacco Users. Am J Epidem 156:730-737, 2002.
  6. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC: Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy. Antimicrob Angents Chemother 46(6): 1896-905, 2002.
  7. Eubanks V, Koppersmith N, Woodridge N, Clancy JP, Lyrene R, Arani RB, Lee J, Moldawer L, Atchison J, Sorscher EJ, Makris CM: Effects of Megestrol Acetate on Weight Gain, Body Composition, and Pulmonary Function in Patients with Cystic Fibrosis. J Pediatr 140(4):439-44, 2002.
  8. Alvarez RD, Huh WK, Khazaeli MB, Meredith RF, Partridge EE, Kilgore LC, Grizzle WE, Shen S, Austin JM, Barnes MN, Carey D, Schlom J, LoBuglio AF. A Phase I Study of Combined Modality 90Yttrium - CC49 Intraperitoneal Radioimmunotherapy for Ovarian Cancer. Clinical Cancer Research 8:2806-2811, 2002.
  9. Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D, Curiel DT. Adenoviral Gene Therapy for Renal Cancer Requires Retargeting to Alternative Cellular Receptors. Cancer Research 62:4273-4281, 2002.
  10. Posey J, Khazaeli MB, Bookman MA, Nowrovzi A, Grizzle WE, Thornton J, Carey D, Lorenz JM, Sing AP, Siegall CB, LoBuglio AF, Saleh MN. A Phase I Trial of the Single Chain Immunotoxin SGN-10 (BR96 sFv – PE40) in Patients with Advanced Solid Tumors. Clinical Cancer Research8:3092-3099, 2002.
  11. Robert F, Spencer SA, Childs HA, Zhang R, Meredith RF, Wheeler RH, Hawkins MH, Carey D. Concurrent Chemoradiation Therapy with Cisplatin and Paclitaxel for Locally Advanced Non-Small Cell Lung Cancer: Long Term Follow-up of a Phase I Trial. Lung Cancer 37:189-199, 2002.
  12. Vaughan WP, Carey D, Perry S, Westfall AO, Salzman DE. A Limited Sampling Strategy for Pharmacokinetic Directed Therapy with Intravenous Bulsulfan. Biology of Blood and Marrow Transplantation 8:619-624, 2002.
  13. Buchsbaum DJ, LoBuglio, AF, Oliver PG, Carpenter M, Zhou T: Treatment of Human Breast Cancer Xenografts with Monoclonal Antibody Against DR5 With or Without Chemotherapy Inhibits Tumor Growth in Nude Mice. Proc Am Assoc Cancer Res 43:1005-1006, 2002.
  14. Buchsbaum D, Rogers B, Khazaeli M, Carpenter M, Safavy A: Treatment of Tumor Xenografts with 177 Lu- and 188 Re-HuCC49 and HuCC49šCH2. J Nucl Med 43:268, 2002.
  15. Buchsbaum DJ, Bonner JA, Grizzle WE, Stackhouse MA, Carpenter M, Hicklin DJ, Bohlen PA, Waksal HW, Raisch KP: Treatment of Pancreatic Cancer Xenografts with IMC C225 Anti-EGFR Antibody, Gemcitabine and Radiation. International Journal Radiation Oncology Biology Phys 54(4):1180-1193, 2002.
  16. Carpenter M , Buchsbaum DJ: Statistical Growth Curve Modeling of Tumors Treated with ERBITUX™ (IMC-C225) Anti-EGFR Antibody, Gemcitabine and Radiation. Proc Am Assoc Cancer Res 43:1005-1006, 2002.
  17. Carpenter DM : Estimation of Location Extremes within General Families of Scale Mixtures. Journal for Statistical Planning and Inference 100:197-208, 2002.
  18. Kaliberov S, Buchsbaum DJ, Gillespie GY, Curiel DT, Arafat W, Carpenter M, Stackhouse MA: Adenovirus-mediated Transfer of Bax Driven by the Vascular Endothelial Growth Factor Promoter Induces Apoptosis in Lung Cancer Cells. Molecular Therapy 6(2):190-198, 2002.
  19. Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS. Immunologic and Virologic Consequences of Antiretroviral Treatment Interruption in Clinical Practice. AIDS Research & Human Retroviruses 18:909-916, 2002.
  20. Johnson PC, Wheat LJ, Cloud GA , Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE, NIAID and the Mycoses Study Group. Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS. Annals of Internal Medicine 137(2):105-109, 2002.
  21. Karimi K, Wheat LJ, Connolly PA, Cloud G, Hajjeh R, Wheat E, Alves K, Silva Lacaz C, Keath E. Differences Between Histoplasmosis in Patients with AIDS in the United States and Brazil. Journal of Infectious Diseases 186(11):1655-60, 2002.
  22. Miller CR, Gustin AN, Buchsbaum DJ, Vickers SM, Manne U, Grizzle WE, Cloud GA , Diasio RB, and Johnson MR. Quantitation of Cytosine Deaminase mRNA by Real-Time Reverse Transcription Polymerase Chain Reaction: A Sensitive Method for Assessing 5-Fluorocytosine Toxicity in Vitro. Analytical Biochemistry 301:189-199, 2002.
  23. Sun Q, Burton R, Reddy V, Pohlman B, Cloud G, Lakeman F, Lucas KG. Adoptive Immunotherapy with Allogeneic Epstein-Barr Virus (EBV) Specific Cytotoxic T Lymphocytes for EBV-related Lymphoma. British Journal of Hematology (11(8):799-808, 2002.
  24. Bachmann LH, Desmond RA , Stephens J, Hughes A, Hook EW. Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women Following Standard Therapy for Uncomplicated Gonorrhea. Journal of Clinical Microbiology 40:3596-601, 2002.
  25. Eloubeidi MA, Desmond RA , Reed CE, Wilcox CM. Prognostic Factors for Survival From Carcinoma in the United States: The Importance of Tumor Length and Lymph Node Status. Cancer 95:1434-1443, 2002.
  26. Gower BA, Weinsier RL, Jordan JM, Hunter GR, Desmond R . Effect of Weight Loss on Changes in Insulin Sensitivity and Lipid Concentrations in Premenopausal African-American and White Women. The American Journal of Clinical Nutrition 76:923-927, 2002.
  27. Hardy RW, Meckling-Gill KA, Williford J, Desmond R, Wei H . Energy Restriction Reduces Long Chain Saturated Fatty Acids Associated with Plasma Lipids in Aging Male Rats. J Nutr 132(10):3172-3177, 2002.
  28. Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes N, Alvarez RD, Curiel DT. In Vivo Molecular Chemotherapy and Non-invasive Imaging with an Infecitivity Enhanced Adenovirus. JNCI 94:741-749, 2002.
  29. Hemminki A, Wang M, Desmond RA, Strong T, Alvarez R, Curiel Dt. Serum and Ascites Neutralizing Antibodies in Ovarian Cancer Patients Treated with Adenoviral Gene Therapy. Human Gene Therapy13:1505- 1514, 2002.
  30. Khuu HM, Desmond R, Huang St, Marques MR. Characteristics of Photophoresis in the Management of Heart and Lung Transplant Patients. Journal of Clinical Apheresis17:27-32, 2002.
  31. Kunerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarex RD, Siegal GD, Curiel DT,Hemminki A. Gene Transfer to Ovarian Cancer VS. Normal Tissues with Fiber Modified Adenovirus. Molecular Therapy the Journal of the American Society of Gene Therapy 5:695-704, 2002.
  32. Lara-Castro L, Weinsier RL, Hunter GR, Desmond R. Visceral Adipose Tissue in Premenopausal Black and White Women: Longitudinal Study of the Effects of Fat Gain, Time and Race. Obesity Research 10:868-874, 2002.
  33. Nagy TR, Krzywanski D, Li J, Meleth S, Desmond RA . Effects of Group Versus Single Housing on Phenotypic Variance in C57B1/6J Mice. Obesity Research 10:412-415, 2002.
  34. Weinsier RL, Hunter GR, Desmond RA, Zuckerman PA, Darnell BE. Free-living Activity Energy Expenditure in Women Successful and Unsuccessful at Maintaining a Normal Body Weight. Am J Clin Nutr. 75(3):499-504, 2002.
  35. Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Ratner L, Pluda JM, Figg WD, Krown SE and Dezube BJ. Matrix Metalloprotinease Inhibitor COL-3 in the Treatment of AIDS-related Kaposi’s Sarcoma: A Phase I AIDS Malignancy Consortium Study. Journal of Clinical Oncology20:153-159, 2002.
  36. Miles SA, Dezube BJ, Lee JY, Fletcher MA, Saville MW, Kaplan LD, Groopman J, Scadden DT, Cooley T, Krown SE, Von Roenn J, Friedman-Kien A for the AIDS Malignancy Consortium. Anti-tumor Activity of Oral 9-cis Retinoic Acid in HIV Infected Patients with Kaposi’s Sarcoma: A Multicenter Trial of the AIDS Malignancy Consortium. AIDS 16:421-429, 2002.
  37. Walsh TJ, Pappas PG, Winston D, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, and Lee J for the NIAID Mycoses Study Group. Voriconazole Versus Lipsomal Amphotericin B for the Empirical Antifungal Therapy in Persistently Febrile Neutropenic Patients: A prospective, Randomized, Multicenter, International Trial. New England Journal of Medicine 346(4):225-234, 2002.
  38. Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, Douglas SD, Korber B, Vermund SH, Kaslow RA. Host Genetic Profiles Predict Virological and Immunological Control of Chronic Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Primarily African-American. AIDS 16: 2275-2289, 2002.
  39. Trask S, Derdeyn C, Fideli U, Chen Y, Meleth S, Kasolo F, Musonda R, Hunter E, Gao F, Allen S, Hahn B. Molecular Epidemiology of HIV-1 Transmission in a Heterosexual Cohort ofDiscordant Couples in Zambia. Journal of Virology 76:397-405, 2002.
  40. Dorak MT, Folayan GO, Niwas S, Yee L, Tang J, van Leeuwen DJ, Kaslow RA: C-C Chemokine Receptor 2 (CCR2) and CCR5 Genotypes in Patients Treated for Chronic Hepatitis C Virus Infection. Immunol Res 26(1-3): 167-175, 2002.
  41. Oster RA . An Examination of Statistical Software Packages for Categorical Data Analysis Using Exact Methods. The American Statistician 56:235-246, 2002.
  42. Acton RT, Barton JC, Casebeer L, Talley LI. A Survey of Physician Knowledge About Hemochromatosis Genetics in Medicine,4(3):136-141, 2002.
  43. Chhieng DC , Talley LI, Roberson JA, Gatscha RM, Elgert PA. Interobserver Variability: Comparison Between Liquid-based and Conventional Preparations in Gynecology Cytology. CancerCytopathology, 96(2):67-73, 2002.
  44. Grizzle WE, Manne U, Weiss H, Jhala N, Talley LI. The Molecular Staging of Colorectal Cancer in African-American and Caucasian Patients Using Phenotypic Expression of p53, Bcl-2, MUC-1, and p27. International Journal of Cancer, 97(4):403-409, 2002.
  45. Talley LI , Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR. Hormone Receptors and Proliferation in Breast Carcinomas of Equivalent Histologic Grades in Pre-and post-menopausal Women. International Journal ofCancer, 98:118-127, 2002.
  46. Bailey, W. C., Gerald, L.B., Kimerling, M. E., Redden, D., Brook, N., Bruce, F., Tang, S., Duncan, S., Brooks, M., Dunlap, N.E. Predictive Model to Identify Positive Tuberculosis Skin Test Results During Contact Investigations. JAMA 287:996-1002, 2002.
  47. Gerald LB, Tang S, Bruce F, Redden D, Kimberling M, Brook N, Dunlap N, Bailey WC. A Decision Tree for Tuberculosis Contact Investigation. The American Journal of Respiratory and Critical Care Medicine 166:1122-1127, 2002.
  48. Tang J., Tang S., Lobashevsky E, Myracle AD, Fideli U, Aldrovandi G, Allen S, Musonda R, Kaslow RA. Favorable and Unfavorable HLA Class I Alleles and Haplotypes in Zambians Predominantly Infected with Clade C Human Immunodeficiency Virus Type 1. J. Virol 76:8276-8284, 2002.
  49. Castor D, Prabhaker P, Furlong C, Rao A, Brown A, Camara B, Weiss H, and Jolly PE. Determinants of Gonorrhoea Infection Among STD Clinic Attenders in Trinidad – I: Sociodemographic factors, Knowledge, Risk Perception and History of STDs. International Journal of STD and AIDS 13:39-45, 2002.
  50. Castor D, Jolly PE, Prabhakar P, Furlong C, Rao A, Brown A, Camara B, and Weiss H. Determinants of Gonorrhoea Infection Among STD Clinic Attenders in Trinidad – II: Sexual Behavioural Factors. International Journal of STD and AIDS 13:46-51, 2002.
  51. Chen DT , Chan W, Francis D. The Mixed Effects Model in the Negative Exponential Curve: An Application of Growth Curve Model to Children’s Reading Ability. Communication in Statistics: Simulation and Computation 31:279-300, 2002.